Savara Inc在2025年欧洲呼吸学会大会上发布Molgramostim吸入溶液治疗自身免疫性肺泡蛋白沉着症患者的3期IMPALA-2临床试验最新数据
Savara Inc在2025年欧洲呼吸学会大会上发布Molgramostim吸入溶液治疗自身免疫性肺泡蛋白沉着症患者的3期IMPALA-2临床试验最新数据
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.